Who founded Generian Pharmaceuticals?

Generian Pharmaceuticals was founded by Bill Chen, Yuan Liu in 2019.

How much funding has Generian Pharmaceuticals raised?

Generian Pharmaceuticals has disclosed $13M raised across 1 round.

Where is Generian Pharmaceuticals headquartered?

Generian Pharmaceuticals is headquartered in Pittsburgh, US.

Generian Pharmaceuticals

Pittsburgh, US · Founded 2019 · Delaware corporation

Generian Pharmaceuticals is a preclinical biotechnology company developing orally available small molecule therapeutics for diseases with high unmet need, particularly conditions currently treated by biologics. It targets age-related diseases including metabolic disorders, neurodegeneration, and inflammation.

Biotech Deep Tech Longevity

Founders & leadership

Generian Pharmaceuticals was founded in 2019 by Bill Chen and Yuan Liu.

Bill ChenVice President, Drug Discovery & Co-Founder

Yuan LiuVice President, Biology & Co-Founder

Hank SaffersteinChief Executive Officer

Beibei ChenNamed on SEC filing

Toren FinkelChief Scientific Officer & Co-Founder

Matthias KleinzNamed on SEC filing

Po-Shun LeeChief Medical Officer

Alan BarberChief Financial Officer

Board

Jeanne CunicelliBoard director

Reported raises · per SEC filings

Form D private placements

$13M disclosed across 1 round · 2019

▶$13MraisedOct 2019 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Beibei ChenDirector
Hank SaffersteinExecutive Officer, Director
Toren FinkelExecutive Officer, Director
Jeanne CunicelliDirector
Matthias KleinzDirector

Offering amount: $20M
Amount sold: $13M
First sale: Sep 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 6

by search overlap

Ascidian Therapeutics12 shared keywordsAscidian Therapeutics is a biotechnology company developing RNA-based therapeutics, with a clinical focus that includes ophthalmology and inherited retinal diseases.

Lyterian Therapeutics9 shared keywordsLyterian Therapeutics is a drug discovery company developing medicines that co-opt protein homeostatic mechanisms to regulate genetically-validated targets and treat disease. It is a therapeutics/biotech company based in South San Francisco.

Viridian Therapeutics7 shared keywordsViridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.

Regeneron NASDAQ: REGN www.regeneron.com6 shared keywordsRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.

Inipharm6 shared keywordsInipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.

Hunterian Medicine5 shared keywordsHunterian Medicine is a gene editing company developing CRISPR-based therapies, with a patented platform that enables delivery through a single adeno-associated virus (AAV) to address the CRISPR delivery problem. The technology aims to create treatments for genetic diseases that currently lack FDA-approved therapies.

Companies competing with Generian Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Generian Pharmaceuticals do?: Generian Pharmaceuticals is a preclinical biotechnology company developing orally available small molecule therapeutics for diseases with high unmet need, particularly conditions currently treated by biologics. It targets age-related diseases including metabolic disorders, neurodegeneration, and inflammation.
Who founded Generian Pharmaceuticals?: Generian Pharmaceuticals was founded by Bill Chen, Yuan Liu in 2019.
How much funding has Generian Pharmaceuticals raised?: Generian Pharmaceuticals has disclosed $13M raised across 1 round.
Where is Generian Pharmaceuticals headquartered?: Generian Pharmaceuticals is headquartered in Pittsburgh, US.